ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 163 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,539,000 | +3.1% | 1,100,000 | 0.0% | 1.58% | -13.0% |
| Q2 2023 | $21,857,000 | +16.0% | 1,100,000 | 0.0% | 1.81% | -18.1% |
| Q1 2023 | $18,843,000 | -12.5% | 1,100,000 | 0.0% | 2.21% | -1.7% |
| Q4 2022 | $21,527,000 | +34.9% | 1,100,000 | +10.0% | 2.25% | +47.5% |
| Q3 2022 | $15,953,000 | +15.9% | 999,588 | -0.0% | 1.53% | +14.8% |
| Q2 2022 | $13,760,000 | -13.2% | 1,000,000 | 0.0% | 1.33% | -13.0% |
| Q1 2022 | $15,860,000 | -27.3% | 1,000,000 | 0.0% | 1.53% | -22.9% |
| Q4 2021 | $21,830,000 | -27.0% | 1,000,000 | 0.0% | 1.98% | +39.7% |
| Q3 2021 | $29,890,000 | -32.5% | 1,000,000 | 0.0% | 1.42% | -38.7% |
| Q2 2021 | $44,290,000 | – | 1,000,000 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |